
Eyenovia EYEN
Quartalsbericht 2025-Q2
hinzugefügt 13.08.2025
Eyenovia Kurshistorie 2011-2026 | EYEN
Kurshistorie Jährlich Eyenovia
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.96 | 1.53 | 3.05 | 4 | 6.06 | 4.48 | 2.85 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.06 | 0.96 | 3.28 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | ||
|
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | ||
|
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | ||
|
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | ||
|
Aptorum Group Limited
APM
|
0.91 | $ 0.9 | -0.02 % | $ 6.62 M | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
19.3 | $ 22.46 | 0.72 % | $ 3.72 B | ||
|
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
Cara Therapeutics
CARA
|
1 | - | -3.03 % | $ 260 M | ||
|
CASI Pharmaceuticals
CASI
|
8.4 | - | - | $ 35.4 M | ||
|
Fennec Pharmaceuticals
FENC
|
5.91 | $ 6.81 | -0.58 % | $ 195 M | ||
|
ChromaDex Corporation
CDXC
|
5.67 | - | -0.88 % | $ 598 M | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
Galectin Therapeutics
GALT
|
2.79 | $ 2.37 | -0.04 % | $ 151 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
0.22 | - | 17.91 % | $ 11.1 M | ||
|
Greenwich LifeSciences
GLSI
|
8.83 | $ 23.76 | -0.96 % | $ 309 M | ||
|
BioNTech SE
BNTX
|
91.2 | $ 101.26 | -0.78 % | $ 27.2 B | ||
|
Checkpoint Therapeutics
CKPT
|
4.04 | - | - | $ 169 M | ||
|
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
4.37 | $ 4.14 | 1.1 % | $ 443 M | ||
|
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 23.67 | 1.07 % | $ 3.01 B | ||
|
Heron Therapeutics
HRTX
|
1.19 | $ 1.19 | 0.01 % | $ 198 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.21 | $ 1.45 | 2.13 % | $ 386 M | ||
|
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
74.2 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | ||
|
InflaRx N.V.
IFRX
|
0.94 | $ 1.81 | 12.11 % | $ 152 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 2.98 | 2.05 % | $ 4.91 M | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
Inventiva S.A.
IVA
|
3.07 | $ 5.14 | 0.19 % | $ 138 M | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
bluebird bio
BLUE
|
0.61 | - | - | $ 546 M |